早产儿视网膜病变治疗前的后极部血管变化
该回顾性研究纳入55例接受治疗的早产儿视网膜病变患儿,评估决定治疗时的血管特征及双眼血管末次正常至决定治疗间的检查间隔;决定治疗时51例(92.7%)有附加病变,3例(5.5%)有前期附加病变,1例(1.8%)两者均无;双眼血管末次正常至决定治疗的间隔为0至49天,42例(76%)至少14天,除1例外均至少7天。
要点
- 决定治疗时51例(92.7%)有附加病变,3例(5.5%)有前期附加病变,1例(1.8%)两者均无。
- 双眼血管末次正常至决定治疗的间隔为0至49天,42例(76%)至少14天,除1例外均至少7天。
- 作者认为窄视野影像筛查应包含整个I区,以识别后极部血管正常但需治疗的罕见病例。
核心结论
- 决定治疗时所有患儿中除1例外均有前期附加病变或附加病变。
- 作者认为窄视野影像筛查应包含整个I区,以识别后极部血管正常但需治疗的罕见早产儿视网膜病变。
- 作者认为若获证实且图像质量足够,每周I区照相筛查可能捕获提示即将需要治疗的改变。
研究设计与样本
- 回顾性研究,纳入2013年6月至2017年5月在学术医学中心新生儿重症监护病房纵向检查并接受治疗的所有早产儿视网膜病变患儿。
- 55例患儿符合纳入标准,平均出生体重733克(范围420–1060克),胎龄25.1周(范围22.9–27.7周),决定治疗时月经后年龄36.7周(范围31.4–43.0周)。
主要发现
- 决定治疗时51例(92.7%)有附加病变,3例(5.5%)有前期附加病变,1例(1.8%)两者均无。
- 双眼血管末次正常至决定治疗的检查间隔为0至49天,42例(76%)至少14天,除1例外均至少7天(98%)。
- 唯一例外为1例决定治疗时既无前期附加病变也无附加病变、但为I区3期早产儿视网膜病变(1型早产儿视网膜病变)的罕见情况。
关键数值与推荐
- 决定治疗时附加病变51例(92.7%)、前期附加病变3例(5.5%)、两者均无1例(1.8%)。
- 双眼血管末次正常至决定治疗的间隔0至49天,至少14天42例(76%),至少7天除1例外(98%)。
临床怎么用
- 作者认为窄视野影像筛查应包含整个I区,以识别后极部血管正常但需治疗的罕见早产儿视网膜病变。
- 作者认为若获证实且图像质量足够,每周I区照相筛查可能捕获提示即将需要治疗的改变。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE:: Some proponents of telemedicine screening for retinopathy of prematurity (ROP) believe a screening system based on posterior pole vessel characteristics is sufficient for identifying infants needing treatment. OBJECTIVE:: To evaluate the vascular characteristics present when it was determined treatment was needed, and the number of days between examinations from when the vessels of both eyes were last noted to be normal until a decision was made to treat. DESIGN:: Retrospective study; June 2013-May 2017 SETTING:: Neonatal intensive care unit; academic medical center PARTICIPANTS:: All infants treated for ROP who were longitudinally examined at our institution MAIN OUTCOMES AND MEASURES:: Vascular characteristics present on clinical examination when it was determined an infant needed treatment and the number of days between examinations from when the vessels of both eyes were last noted to be normal until a decision was made to treat. RESULTS:: 55 infants met eligibility criteria, with mean birthweight 733g (range: 420–1060), gestational age 25.1 weeks (range: 22.9–27.7), and post menstrual age at the time a decision was made to treat 36.7 weeks (range: 31.4–43.0). When it was determined an infant needed treatment, 51 (92.7%) had plus disease, 3 (5.5%) pre-plus, and one (1.8%) neither. The number of days between examinations from when an infant was noted to have normal vessels bilaterally until a decision was made to treat was 0 to 49 days. The interval was at least 14 days for 42 infants (76%) and at least 7 days for all but one infant (98%). The exception was one infant with the rare scenario of neither pre-plus nor plus with zone I, stage 3 ROP (type 1 ROP) at the time the examiner decided to treat. CONCLUSIONS AND RELEVANCE:: At the time it was determined an infant needed treatment for ROP, all but one infant had pre-plus or plus disease. These results suggest that narrow-field imaging for ROP screening should include all of zone I, to identify the rare treatment-requiring ROP with normal posterior pole vessels. If confirmed, with sufficient image quality, weekly photographic screening of zone I likely should capture changes indicative of impending treatment-requiring ROP.
引用
- Prakalapakorn SG, Wallace DK, Freedman SF, et al. Posterior Pole Vascular Changes Before Treatment of Retinopathy of Prematurity. JAMA Ophthalmol. 2017. PMID: 29098279. doi:10.1001/jamaophthalmol.2017.4608
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。